Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Saudi Arabia

 

Fakeeh Care Group and Fosun Pharma sign strategic partnership

Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.

‘Saudization’ kickstarts in Saudi Arabia’s healthcare sector

The first phase of ‘Saudization’ in Saudi Arabia’s healthcare sector is now underway, effective from 17 April. Saudization is a government policy to increase the number of Saudi nationals employed and reduce the reliance on expats in the workforce. 

FREE BLOG Blog: To Paris, and beyond!

There’s a palpable sense of purpose within the HBI team, who I can report are relishing the prospect of hosting the industry we serve in Paris for the very first time later this month. If you’re reading this and haven’t yet got your ticket, it’s not too late to book now. Please join us for […]

Saudi Arabia’s SMC Hospitals eyes IPO

Saudi Arabian healthcare group SMC Hospitals is planning an initial public offering in Riyadh, as part of a trend of healthcare firms going public in the kingdom.

Exploring the GCC’s prospective $11 billion GLP-1 RA market — ‘a unique opportunity to lead in this space’

Demand for GLP-1 receptor agonists (the class of drugs used to treat obesity and diabetes) has been growing rapidly, opening up more and more opportunities in the market, such as ‘holistic’ online prescription services. We’ve seen both the positives and negatives of the use of GLP-1 RAs in the US and Europe, from transforming people’s health for the better to misuse and inappropriate supply. But what do we know about the market in the Middle East?

HBI 2024 Day Two, Afternoon Briefing

The afternoon of day two of HBI 2024 included sessions on dental services, veterinary services the move to preventive healthcare, decarbonisation and the race to decarbonise.

Find Us